Transcriptomics referred to as gene expression profiling is the quantitative study of genes expressed in a biological state. Advanced technologies enables quantitative assessment of all expressed genes (transcriptome) in a given tissue. These advancements provide a powerful tool for understanding biological systems and for developing novel biomarkers. Transcriptomics has powerful impact on the field of cardiovascular biomarkers and several transcriptome biomarkers are accessible for clinical research. Transcriptomics have shown that aggregate measures comprised of multiple genes are also informative as biomarkers of complex disease.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: The Biomarkers consortium, International Society for Oncology and Biomarkers, Biomarkers profile corporation, World Molecular Imaging Society, European Society of Molecular Imaging, Biomarkers Society, Society of Nuclear Medicine and Molecular Imaging